Gapping up
In reaction to earnings/guidance:
- BK +4.4%, BAC +2.9%, NYMT +2.1% (guidance), WIT +1.1% (guidance)
Select ETFs trading higher:
- IWM +1.5%, QQQ +1.3%, SPY +1.2%, DIA +1%
Other news:
- LFG +53.1% (to be acquired by bp (BP) for ~$4.1 bln)
- MIST +31.9% (Positive Results from Phase 3 RAPID Clinical Trial of Etripamil Nasal Spray in Patients with Paroxysmal Supraventricular Tachycardia)
- CLR +8.3% (to be acquired by the Hamm Family for $74.28 per share)
- AVXL +5.7% (Late-Breaking Presentation of Phase 2b/3 Data of Oral ANAVEX 2-73)
- CIXX +4.9% (reports total assets of $338.1 billion as at September 30)
- MUFG +3.8% (receives approval from the U.S. Federal Banking Regulators for the sale of MUFG Union Bank to U.S. Bancorp (USB) )
- BKSY +3.4% (files for $200 mln mixed securities shelf offering)
- CS +3.2% (settles RMBS Legacy Case)
- NWSA +3% (confirms receipt of letters from Rupert Murdoch regarding potential combination with Fox)
- SPB +2.5% (ASSA ABLOY formally responds to the DOJ's complaint to block the acquisition of the Hardware and Home Improvement division of Spectrum Brands (SPB))
- GSK +2.1% (receives FDA approval for new presentation of Menveo)
- BP +2.1% (to acquire LFG for $4.1 bln)
- UBER +1.8% (Uber Eats partners with Leafly (LFLY) to bring cannabis delivery to Torontonians)
Analyst comments:
- CHD +3.4% (upgraded to Equal-Weight from Underweight at Morgan Stanley)